BMS, KPMG deploy Claude across 306,000 staff

Bristol Myers Squibb and KPMG disclosed separate Anthropic deals this week that together put Claude in front of more than 306,000 workers, one of the clearest recent signs of large-scale enterprise adoption for Anthropic’s AI products. KPMG said on May 19 that its 276,000-plus global workforce will be given access to Claude as part of a global alliance that also embeds the model in the firm’s client-delivery platform. Bristol Myers said on May 20 that it will deploy Claude across more than 30,000 employees in research, clinical development, manufacturing, commercial and corporate functions. ### Which company moved first, and what exactly did it announce? KPMG said on May 19 that it had launched “KPMG Digital Gateway Powered by Claude,” bringing Anthropic’s model into the software platform KPMG uses with clients and internally. The firm said the initial focus is on tax clients and private equity firms, and that Anthropic has named KPMG a preferred consultant for private equity. (kpmg.com) Bristol Myers Squibb said on May 20 that it had signed a strategic agreement with Anthropic to make Claude Enterprise the company’s “shared intelligence platform” across global operations. The drugmaker said the deployment is intended to connect people, systems and institutional knowledge at enterprise scale, moving beyond what it described as conversational AI. (kpmg.com) ### Where inside KPMG is Claude being used? KPMG said Claude is being embedded inside Digital Gateway, its global client-delivery platform, with new capabilities first aimed at tax and legal clients. The company said KPMG in the United States will also embed Claude into private-equity-focused product offerings and co-develop new Claude-powered products for portfolio companies with Anthropic. (news.bms.com) Anthropic said in its own announcement that the alliance also covers internal business functions and cybersecurity work. The company said KPMG and Anthropic teams will use Claude to identify and fix vulnerabilities in critical systems, with that work guided by KPMG’s Trusted AI framework. ### Where inside Bristol Myers will Claude go? Bristol Myers said the rollout covers research, clinical development, manufacturing, commercial and corporate functions. (kpmg.com) The company said more than 30,000 employees will receive access to Claude’s reasoning and agentic capabilities. (anthropic.com) Reuters reported on May 20 that Bristol Myers is using the partnership in an effort to accelerate the discovery, development and delivery of new medicines. The Wall Street Journal separately reported that the agreement helps extend Anthropic’s push into life sciences as it seeks more enterprise customers. (news.bms.com) ### Why do these two rollouts stand out? The combined figure from the two announcements is at least 306,000 employees: more than 276,000 at KPMG and more than 30,000 at Bristol Myers. Those totals come from company statements released a day apart and cover two different sectors, professional services and pharmaceuticals. KPMG’s announcement is notable because it ties employee access to a named client platform and specific use cases in tax, legal and private equity. (msn.com) Bristol Myers’ announcement is notable because it places Claude across regulated functions that include clinical development and manufacturing, according to the company. ### What happens next in each deployment? (kpmg.com) KPMG said the next phase begins with tax clients and private equity firms using Claude inside Digital Gateway, with additional co-developed products planned for portfolio companies. The company also said Claude will be brought into more business functions over time. Bristol Myers said its next step is a companywide deployment across the functions named in its May 20 statement, with Claude positioned as the group’s shared intelligence platform. (kpmg.com) Anthropic and Bristol Myers did not disclose financial terms in the materials reviewed. (news.bms.com)